Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II.
Saved in:
| Title: | Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II. |
|---|---|
| Authors: | Dodick, David W.1, Lipton, Richard B.2, Ailani, Jessica3 Jessica.X.Ailani@gunet.georgetown.edu, Halker Singh, Rashmi B.1, Shewale, Anand R.4, Zhao, Sihui5, Trugman, Joel M.5, Yu, Sung Yun5, Viswanathan, Hema N.4 |
| Source: | Headache: The Journal of Head & Face Pain. Apr2020, Vol. 60 Issue 4, p686-700. |
| Database: | SPORTDiscus with Full Text |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
